Why Terns Pharmaceuticals Stock Rocked the Market in March
All told, the transaction is valued at around $6.7 billion. If all goes well, it'll close this quarter.
Open original sourceLoading market dashboard
All told, the transaction is valued at around $6.7 billion. If all goes well, it'll close this quarter.
Open original source